Skip to main content

Table 3 Management, resection margin, and recurrence status after hepatectomy

From: Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis

 

Centrally located

Peripherally located

P values

( n = 24)

( n = 135)

Neoadjuvant chemotherapy

4 (16.7%)

11 (8.1%)

0.247

 Effective (stable, partial/complete response

0 (0.0%)

4 (36.4%)

0.159

 Progression

4 (100%)

7 (63.6%)

 

Anatomic resectiona

7 (29.2%)

25 (18.5%)

0.269

Resection margin (mm)

 Involved

10 (41.7%)

20 (14.8%)

0.003

 <10 mm

13 (54.2%)

85 (63.0%)

 

 ≥10 mm

1 (4.2%)

30 (22.2%)

 

Recurrence after hepatectomy

22 (91.7%)

100 (74.1%)

0.045

 Confined in the liver, lung, or both

7 (31.8%)

31 (31.0%)

1.000

 Recurrence in other distant organ(s)

15 (68.2%)

69 (69.0%)

 

Early recurrenceb

9 (37.5%)

24 (17.8%)

0.032

Repeated hepatectomy

1 (4.2%)

13 (9.6%)

0.696

  1. aAnatomic resection includes left or right lobectomy, extended left/right lobectomy, or lateral segmetectomy; combination with other hepatectomy methods is excluded; bEarly recurrence: less than 4 months after the hepatectomy for the first liver metastasis.